MicroRNA Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links Tumorigenesis and Recurrence with Obesity
Overview
Affiliations
Background: Twenty to 40% localised RCC patients may experience recurrence after curative surgery. Limited miRNA predictors have been identified for ccRCC recurrence.
Methods: Through a multi-phase study design, we analysed miRNAs in tissues obtained from 203 ccRCC patients. Paired t-test was used for tumour-normal comparisons and Cox regression model was performed to compute hazard ratios (HRs) and corresponding 95% CIs.
Results: A 17-miRNA signature was identified that can concordantly classify >95% of tumour/adjacent normal samples. Significant enrichment was found as 6 out of 17 miRNAs were associated with obesity (binomial probability=0.001). Decreased levels of miR-204-5p and miR-139-5p were each associated with an approximately three-fold increased risk of recurrence (P<0.01). Risk score was generated based on expressions of miR-204-5p and miR-139-5p, and the trend test was significant in both discovery and validation sets (P<0.05). Striking MST reduction was observed for patients with a high-risk score (high vs low: discovery, 9.4 vs >97.7 months; validation, 20.8 vs >70.3 months). Expressions of miR-204-5p were also associated with body mass index (β=5.64, P<0.001). Significant inverse correlations were observed and validated between miR-204-5p and 13 obesity-related genes (r<0, P<0.01).
Conclusions: We identified 17 miRNAs dysregulated in ccRCC tissues and showed that low expressions of miR-204-5p and miR-139-5p were associated with the higher risk of recurrence. The link between miR-204-5p and ccRCC recurrence may be partially mediated by regulating the expression of targeted obesity-related genes.
Deng J, Tu S, Li L, Li G, Zhang Y Cancer Rep (Hoboken). 2024; 7(6):e2116.
PMID: 38837683 PMC: 11150078. DOI: 10.1002/cnr2.2116.
Shen T, Song Y, Wang X, Wang H Front Mol Biosci. 2022; 9:967934.
PMID: 36090028 PMC: 9459094. DOI: 10.3389/fmolb.2022.967934.
Renal Cell Cancer and Obesity.
Gluba-Brzozka A, Rysz J, Lawinski J, Franczyk B Int J Mol Sci. 2022; 23(6).
PMID: 35328822 PMC: 8951303. DOI: 10.3390/ijms23063404.
Liu Q, Lei C Ann Med. 2021; 53(1):2153-2164.
PMID: 34783622 PMC: 8604453. DOI: 10.1080/07853890.2021.2001563.
Liu Y, Liu Y, Hu J, He Z, Liu L, Ma Y Front Endocrinol (Lausanne). 2021; 12:713357.
PMID: 34621242 PMC: 8490801. DOI: 10.3389/fendo.2021.713357.